Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision tag Revision: v3.5.4 was added and the previous Revision: v3.5.3 was removed, reflecting an update to the page's versioning metadata. This indicates a maintenance update to the page's documentation rather than changes to study content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, signaling a small internal version update to the page. There are no changes to the study data or displayed content.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision was updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now displays revision: v3.4.3 in place of the previous v3.4.2.SummaryDifference0.1%

- Check101 days agoChange DetectedRevision: v3.4.2 was applied to the site, and the previous notice about government funding operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.